worldwiki
governmentEvidence level AIndependent
Evidence page

Regenerative Medicine Advanced Therapy Designation

U.S. Food and Drug Administration

Published Nov 4, 2025accessed Nov 10, 2026Updated Nov 10, 2026
Original source

https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/regenerative-medicine-advanced-therapy-designation

fda.gov

Verification

VerificationIndependent of the subject
Evidence levelA · Government / regulator
IndependentIndependent of the subject
Sourcegovernment
Link statusReachable at last check

Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise. Source policy

Cited by (7)

FactRegenerative Medicine: U.S. legal definition (RMAT) = A cell therapy, therapeutic tissue engineering product, human cell and tissue product, or any combination of these; certain human gene therapies and xenogeneic cell products may also qualify (FD&C Act section 506(g))FactRegenerative Medicine: RMAT designation criteria = Must be a regenerative medicine therapy intended for a serious or life-threatening condition, with preliminary clinical evidence of potential to address unmet medical needs (21st Century Cures Act section 3033)Answer"미국 FDA RMAT 지정을 받았다"는 홍보 문구는 허가를 받았다는 뜻인가요?Answer米国のRMAT指定を受けている、と説明されました。これは承認された治療という意味ですか？Answer中介说这款疗法「获得美国FDA的RMAT认定」，是不是等于已经批准上市？Answer再生医学里，哪些治疗已经是成熟的常规医疗，哪些还只是研究阶段？Answerقيل لي ان العلاج حاصل على تصنيف RMAT من FDA الامريكية، فهل يعني ذلك انه دواء مرخص؟